Systemic delivery of targeted nanotherapeutic reverses angiotensin II-induced abdominal aortic aneurysms in mice
Abstract Abdominal aortic aneurysm (AAA) disease causes dilation of the aorta, leading to aortic rupture and death if not treated early. It is the 14th leading cause of death in the U.S. and 10th leading cause of death in men over age 55, affecting thousands of patients. Despite the prevalence of AA...
Guardado en:
Autores principales: | Xiaoying Wang, Vaideesh Parasaram, Saphala Dhital, Nasim Nosoudi, Shahd Hasanain, Brooks A. Lane, Susan M. Lessner, John F. Eberth, Naren R. Vyavahare |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/895b007d529646f1a277f035ac199b80 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Author Correction: Systemic delivery of targeted nanotherapeutic reverses angiotensin II‑induced abdominal aortic aneurysms in mice
por: Xiaoying Wang, et al.
Publicado: (2021) -
MFAP4 Deficiency Attenuates Angiotensin II-Induced Abdominal Aortic Aneurysm Formation Through Regulation of Macrophage Infiltration and Activity
por: Bartosz Pilecki, et al.
Publicado: (2021) -
CRP immunodeposition and proteomic analysis in abdominal aortic aneurysm.
por: Eun Na Kim, et al.
Publicado: (2021) -
Antiphospholipid antibodies predict progression of abdominal aortic aneurysms.
por: Christina Duftner, et al.
Publicado: (2014) -
Use of intravascular ultrasound in endovascular repair of abdominal aortic aneurysm
por: Łukasz Dzieciuchowicz, et al.
Publicado: (2020)